Cargando…
FlipGFP protease assay for evaluating in vitro inhibitory activity against SARS-CoV-2 M(pro) and PL(pro)
FlipGFP assay characterizes the intracellular drug target engagement to M(pro) and PL(pro) and can be performed in the biosafety level 1/2 settings. Here, we provide the detailed protocol for the cell-based FlipGFP assay to identify and characterize SARS-CoV-2 M(pro) and PL(pro) inhibitors. We descr...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10156985/ https://www.ncbi.nlm.nih.gov/pubmed/37329507 http://dx.doi.org/10.1016/j.xpro.2023.102323 |
_version_ | 1785036649185411072 |
---|---|
author | Tan, Haozhou Hu, Yanmei Wang, Jun |
author_facet | Tan, Haozhou Hu, Yanmei Wang, Jun |
author_sort | Tan, Haozhou |
collection | PubMed |
description | FlipGFP assay characterizes the intracellular drug target engagement to M(pro) and PL(pro) and can be performed in the biosafety level 1/2 settings. Here, we provide the detailed protocol for the cell-based FlipGFP assay to identify and characterize SARS-CoV-2 M(pro) and PL(pro) inhibitors. We describe steps for cell passage and seeding, transfection, addition of compounds, and their incubation and timing. We then detail the quantification of the fluorescence signal of the assay For complete details on the use and execution of this protocol, please refer to Ma et al.(1) |
format | Online Article Text |
id | pubmed-10156985 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-101569852023-05-04 FlipGFP protease assay for evaluating in vitro inhibitory activity against SARS-CoV-2 M(pro) and PL(pro) Tan, Haozhou Hu, Yanmei Wang, Jun STAR Protoc Protocol FlipGFP assay characterizes the intracellular drug target engagement to M(pro) and PL(pro) and can be performed in the biosafety level 1/2 settings. Here, we provide the detailed protocol for the cell-based FlipGFP assay to identify and characterize SARS-CoV-2 M(pro) and PL(pro) inhibitors. We describe steps for cell passage and seeding, transfection, addition of compounds, and their incubation and timing. We then detail the quantification of the fluorescence signal of the assay For complete details on the use and execution of this protocol, please refer to Ma et al.(1) Elsevier 2023-05-04 /pmc/articles/PMC10156985/ /pubmed/37329507 http://dx.doi.org/10.1016/j.xpro.2023.102323 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Protocol Tan, Haozhou Hu, Yanmei Wang, Jun FlipGFP protease assay for evaluating in vitro inhibitory activity against SARS-CoV-2 M(pro) and PL(pro) |
title | FlipGFP protease assay for evaluating in vitro inhibitory activity against SARS-CoV-2 M(pro) and PL(pro) |
title_full | FlipGFP protease assay for evaluating in vitro inhibitory activity against SARS-CoV-2 M(pro) and PL(pro) |
title_fullStr | FlipGFP protease assay for evaluating in vitro inhibitory activity against SARS-CoV-2 M(pro) and PL(pro) |
title_full_unstemmed | FlipGFP protease assay for evaluating in vitro inhibitory activity against SARS-CoV-2 M(pro) and PL(pro) |
title_short | FlipGFP protease assay for evaluating in vitro inhibitory activity against SARS-CoV-2 M(pro) and PL(pro) |
title_sort | flipgfp protease assay for evaluating in vitro inhibitory activity against sars-cov-2 m(pro) and pl(pro) |
topic | Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10156985/ https://www.ncbi.nlm.nih.gov/pubmed/37329507 http://dx.doi.org/10.1016/j.xpro.2023.102323 |
work_keys_str_mv | AT tanhaozhou flipgfpproteaseassayforevaluatinginvitroinhibitoryactivityagainstsarscov2mproandplpro AT huyanmei flipgfpproteaseassayforevaluatinginvitroinhibitoryactivityagainstsarscov2mproandplpro AT wangjun flipgfpproteaseassayforevaluatinginvitroinhibitoryactivityagainstsarscov2mproandplpro |